NASDAQ
Cardlytics, Inc. (CDLX)
♥ 382 Thanks from members
Cardlytics, Inc. (CDLX) displays a mixed financial narrative following its Q2 2026 results, characterized by positive adjusted EBITDA and completed strategic divestitures, balanced against revenue contractions from partner exits and weak alternative data sentiment scores.